Breast Cancer Clinical Trials

Find Breast Cancer Clinical Trials Near You

Dissemination of a Breast Reconstruction Decision Tool Through Social Media and Online Communities- AIM1-B

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This registration covers only Aim 1b, which focuses on testing usability. The study will include 20 participants who are breast cancer patients. Participants will be observed using the tool on their mobile devices, and their experience will be evaluated using a think-aloud method to capture their thoughts and reactions. Interviews will include open-ended questions about the content and format of the decision aid, with follow-up prompts to gather feedback on design elements (length, order, graphics), comprehension, ease of use, acceptance, and engagement with the tool. Knowledge will be measured using the Decision Quality Instrument before and after using the tool. Results will be analyzed to develop recommendations for the final version of the tool.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥ 18 years at the time of consent

• Able to read and speak English.

• Have had surgery, such as a mastectomy or lumpectomy, to remove some or all of their breast or breasts.

• Breast surgery occurred within the past 8 years.

• Breast surgery was due to a diagnosis of breast cancer, ductal carcinoma in situ, or risk of future breast cancer, by participant report.

• Sex was assigned Female at birth

Locations
United States
North Carolina
The University of North Carolina
RECRUITING
Chapel Hill
Contact Information
Primary
Victoria Triana
Victoria_Triana@med.unc.edu
919-966-4320
Backup
Kathryn A Chetwynd
Kathryn_Chetwynd@med.unc.edu
919-966-4320
Time Frame
Start Date: 2025-10-01
Estimated Completion Date: 2029-01-20
Participants
Target number of participants: 20
Treatments
Experimental: Breast cancer survivors
Breast cancer survivors.
Related Therapeutic Areas
Sponsors
Leads: UNC Lineberger Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov